Ipsen appoints Michelle C. Werner as EVP, President of North America
· Financial Post
“I am very pleased to welcome Michelle to Ipsen and to the Executive Leadership Team. She brings a wealth of experience in leading teams both in the U.S. and around the world and has a deep understanding of the United States and all the great opportunities that this market offers for Ipsen at a moment when we are accelerating the growth of our portfolio in rare diseases, oncology and neurosciences. These are therapeutic areas where Michelle has excelled over her extensive career” declared David Loew, CEO. Read More
Visit catcross.org for more information.